2023
DOI: 10.3389/fimmu.2023.1241600
|View full text |Cite
|
Sign up to set email alerts
|

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

María Belén Sanchez,
Bianca Vasconcelos Cordoba,
Carolina Pavlovsky
et al.

Abstract: IntroductionTreatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is available. However, the question arises as to which factors can contribute to the maintenance of TFR, and immunologic surveillance of the remaining leukemic cells is believed to be one of them. Argentina Stop Trial is an open-label, single-arm, multicenter trial assessing TFR after tyrosine kinase inhibitors interruption, that after more than 4 ye… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…At the microscopic level, all NK cells are visually similar and appear to be large, granular lymphocytes. However, with modern immunophenotyping, many different NK cell lineages can be delineated with a diverse array of proteins, receptors, and signaling molecules on their surface [45][46][47].…”
Section: Introductionmentioning
confidence: 99%
“…At the microscopic level, all NK cells are visually similar and appear to be large, granular lymphocytes. However, with modern immunophenotyping, many different NK cell lineages can be delineated with a diverse array of proteins, receptors, and signaling molecules on their surface [45][46][47].…”
Section: Introductionmentioning
confidence: 99%